| Date | Title | File |
|---|---|---|
|
Dec 12, 2022
|
ASH 2022: Corporate Presentation on LIMBER Program
|
|
|
Nov 01, 2022
|
Q3 2022 Financial and Corporate Update Presentation
|
|
|
Aug 02, 2022
|
Q2 2022 Financial and Corporate Update Presentation
|
|
|
Jul 19, 2022
|
Opzelura™ in Vitiligo FDA Approval Presentation
|
PDF 4.8 MB
|
|
May 03, 2022
|
Q1 2022 Financial and Corporate Update Presentation
|
|
|
Feb 08, 2022
|
Q4 2021 Financial and Corporate Update Presentation
|
|
|
Jan 10, 2022
|
J.P. Morgan 40th Annual Virtual Healthcare Conference
|
|
|
Nov 13, 2021
|
SITC 2021: Corporate Presentation on Oral PD-L1 Program
|
Presentation 1.8 MB
|
|
Nov 02, 2021
|
Q3 2021 Financial and Corporate Update Presentation
|
|
|
Sep 27, 2021
|
GVHD Update Presentation
|
GVHD Update Presentation 950.6 KB
|
